# Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

> **NCT01694381** · EARLY_PHASE1 · TERMINATED · sponsor: **TSI, LLC** · enrollment: 8 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** M5
- **DRUG:** C1-inhibitor

## Key facts

- **NCT ID:** NCT01694381
- **Lead sponsor:** TSI, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694381, "Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01694381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*